PointCross at Phuse APAC Connect 2026
PointCross Life Sciences was proud to participate in PHUSE APAC Connect 2026, held from 19–21 February 2026 in Hyderabad, India. The event brought together global leaders across clinical data science, innovation, and regulatory standards, alongside India CDISC Day, uniting two...
Revolutionary Single – Track Process Transforms Nonclinical Data Management
Xbiom™ Platform Introduces AI-Enabled Automated Workflow that Eliminates Redundant Processes, Reduces Costs by 50%, and Accelerates IND-Enabling Regulatory Submission Readiness by 2-4 Weeks. Foster City, CA, December 18, 2025 PointCross today announced general availability of an AI augmented transformative single-track...
Does my Study need SEND?
As a toxicologist running multiple GLP and non-GLP studies, you and your team often plan budgets, study schedules, and contracting activities with your CRO and external vendor labs. There is, often times, one critical-path topic that often appears as a...
PHUSE EU Connect 2025
Event Date: 16 – 19 November 2025Location: Hamburg, Germany 𝐀𝐬 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐝𝐚𝐭𝐚 𝐠𝐫𝐨𝐰𝐬 𝐦𝐨𝐫𝐞 𝐜𝐨𝐦𝐩𝐥𝐞𝐱, 𝐦𝐞𝐭𝐚𝐝𝐚𝐭𝐚 𝐜𝐚𝐧’𝐭 𝐛𝐞 𝐚𝐧 𝐚𝐟𝐭𝐞𝐫𝐭𝐡𝐨𝐮𝐠𝐡𝐭.At PHUSE EU Connect 2025, Harinarayan Gopichandran, VP Technical Solutions at PointCross, demonstrated how the 𝐗𝐛𝐢𝐨𝐦 𝐒𝐦𝐚𝐫𝐭 𝐌𝐞𝐭𝐚𝐝𝐚𝐭𝐚 𝐑𝐞𝐩𝐨𝐬𝐢𝐭𝐨𝐫𝐲 (𝐌𝐃𝐑) helps Sponsors and...
Refreshing Clinical Data Validation for Modern BioPharma
Validation and study data quality should be thought of as iterative and continuous workflows. Yet, many teams still work within usage models and contract terms that make it harder to validate for rules and conformance checks as often as needed....
PointCross at PHUSE SDE Bengaluru 2025 – Gold Sponsor
Event Date: Saturday, 22 November 2025Location: Bengaluru, India About the Event The PHUSE Single Day Event (SDE) in Bengaluru brought together leaders across the clinical research ecosystem to discuss how emerging technologies -AI, ML, RPA, and intelligent data systems are...
Metadata Repository: Your Strategic Edge in Clinical Development
Most research organizations spend 16-20 weeks setting up each clinical trial. Six of those weeks go to creating SDTM datasets alone. This isn’t just slow. It’s expensive, risky, and getting worse as regulatory requirements grow more complex. The problem isn’t...
Bridging the Gap: How Natural Language AI Can Transform Clinical Data Access
As the BioPharma industry evolves toward more data-intensive, portfolio-wide agile decision-making, under pressure to innovate and reduce the time to market, organizations that master bridging the questions of their staff to regulatory compliant, verifiable responses retrieved from their study data...
Ask with Ease. Retrieve with Rigor. Study Data Secured by RAG-Enabled Chat in Xbiom
The biopharmaceutical industry is entering a new era where the ability to harness data directly determines the speed and success of drug development. Clinical trials, nonclinical studies, and biomarker assays now generate massive volumes of complex data. When unified and...
How Leaders Can Shape Drug Success Through Data
The Case for Faster, Smoother Approvals Every day saved in the approval process matters. Faster reviews mean therapies reach patients sooner, investors see value earlier, and science delivers its impact without avoidable setbacks. The encouraging news is that most delays...
